Afibrinogenaemia
| Congenital afibrinogenemia | |
|---|---|
| Classification and external resources | |
| Specialty | hematology |
| ICD-10 | D68.2 |
| ICD-9-CM | 286.3 |
| OMIM | 202400 |
| DiseasesDB | 307 |
| MedlinePlus | 001313 |
| eMedicine | ped/3042 |
| MeSH | D000347 |
Congenital afibrinogenemia is a rare, genetically inherited blood disorder in which the blood does not clot normally due to the lack of fibrinogen, a blood protein necessary for coagulation. This disorder is autosomal recessive, meaning that two unaffected parents can have a child with the disorder. The lack of fibrinogen expresses itself with excessive and, at times, uncontrollable bleeding.
As this is a disorder that is present in an individual from birth, there are no warning signs to look for. The first symptom usually seen is hemorrhage from the umbilical cord that is difficult to stop.
Other symptoms include:
Spontaneous bleeding of the mouth, nose, and gastrointestinal tract are common. Since blood clots can not be formed, minor injuries tend to lead to excessive bleeding or bruising. The biggest concern for individuals with afibrogenemia is CNS hemorrhage, bleeding in the brain, which can be fatal.
Many of these symptoms are chronic, and will continue to occur for the entirety of the affected individual's life.
A missense or nonsense mutation to the genes that code for the fibrinogen protein are affected. Usually the mutation leads to an early stop in the production of the protein. Due to the problem being genetically based, there is no way to prevent the disease. Individuals can get genetic testing done to see if they are a carrier of the trait, and if so may choose to complete genetic counseling to better understand the disorder and help manage family planning. Parents can choose to do prenatal genetic testing for the disorder to determine if their child will have the disease. The only risk factor is if both parents of a child carry the recessive allele linked to the disorder.
Individuals with the disorder have a mutation to their fibrinogen gene that prevents the formation of the protein. In normal conditions, fibrinogen is converted to fibrin when it is cleaved by the enzyme thrombin in the blood. The newly formed fibrin forms a fiber-rich network that helps trap red blood cells to start the coagulation process and form a clot. Since there is no fibrinogen present during afibrogenemia, fibrin can not be formed to aid in this process.
When a problem of fibrinogen is suspected, the following tests can be ordered:
Blood fibrinogen levels of less than 0.1 g/L and prolonged bleeding test times are indicators of an individual having afibrogenemia.
...
Wikipedia